News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Kazunari Yoshida, MD, PhD

Articles by Kazunari Yoshida, MD, PhD

Using Pharmacogenetics in Making Treatment Decisions for Schizophrenia

ByKazunari Yoshida, MD, PhD,Daniel J. Müller, MD, PhD

March 29th 2019

Latest Updated Articles

Using Pharmacogenetics in Making Treatment Decisions for Schizophrenia
Published: March 29th 2019 | Updated:

Trending on Psychiatric Times

The Deadly Days and What Makes Life Worth Living Better

Presenting Our November Theme: Best Practices

Correctional Psychiatry Enters a New Era: NCCHC Releases 2026 Mental Health Standards

© 2025 MJH Life Sciences^®

All rights reserved.